Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

ClinicalTrials.gov ID: NCT02338960

Public ClinicalTrials.gov record NCT02338960. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Double-blind, Placebo-controlled, Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Subcutaneously Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an optional Open-label Extension to evaluate the efficacy of bremelanotide (BMT), administered subcutaneously (SC) on an as needed basis for the treatment of HSDD (with or without decreased arousal) in premenopausal females.

Study identification

NCT ID
NCT02338960
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Palatin Technologies, Inc
Industry
Enrollment
714 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2015 (Type not available)
Primary completion
Aug 2016 (Actual)
Completion
Jun 29, 2017 (Actual)
Last update posted
Jan 28, 2021

2015 – 2017

United States locations

U.S. sites
87
U.S. states
35
U.S. cities
81
Facility City State ZIP Site status
Palatin Clinical Site 242 Birmingham Alabama 35242 —
Palatin Clinical Site 218 Phoenix Arizona 85032 —
Palatin Clinical Site 254 Tucson Arizona 85712 —
Palatin Clinical Site 207 Hot Springs Arkansas 71901 —
Palatin Clinical Site 258 Beverly Hills California 90210 —
Palatin Clinical Site 256 Garden Grove California 92845 —
Palatin Clinical Site 291 Los Angeles California 90024 —
Palatin Clinical Site 270 Oakland California 94612 —
Palatin Clinical Site 210 San Diego California 92120 —
Palatin Clinical Site 251 San Diego California 92123 —
Palatin Clinical Site 272 Sherman Oaks California 91403 —
Palatin Clinical Site 253 Tarzana California 91356 —
Palatin Clinical Site 212 Denver Colorado 80209 —
Palatin Clinical Site 219 Denver Colorado 80220 —
Palatin Clinical Site 243 Lakewood Colorado 80228 —
Palatin Clinical Site 211 New London Connecticut 06320 —
Palatin Clinical Site 229 Waterbury Connecticut 06708 —
Palatin Clinical Site 202 Washington D.C. District of Columbia 20036 —
Palatin Clinical Site 204 Aventura Florida 33180 —
Palatin Clinical Site 273 Coral Gables Florida 33134 —
Palatin Clinical Site 203 Fort Myers Florida 33912 —
Palatin Clinical Site 255 Gainesville Florida 32607 —
Palatin Clinical Site 266 Gainesville Florida 32607 —
Palatin Clinical Site 224 Jupiter Florida 33458 —
Palatin Clinical Site 250 Orlando Florida 32806 —
Palatin Clinical Site 261 Oviedo Florida 32765 —
Palatin Clinical Site 260 Pinellas Park Florida 33781 —
Palatin Clinical Site 236 West Palm Beach Florida 33409 —
Palatin Clinical Site 248 Alpharetta Georgia 30005 —
Palatin Clinical Site 263 Atlanta Georgia 30328 —
Palatin Clinical Site 288 Addison Illinois 60101 —
Palatin Clinical Site 252 Chicago Illinois 60640 —
Palatin Clinical Site 201 Chicago Illinois 60654 —
Palatin Clinical Site 277 Indianapolis Indiana 46260 —
Palatin Clinical Site 247 Prairie Village Kansas 66206 —
Palatin Clinical Site 286 Paducah Kentucky 42003 —
Palatin Clinical Site 279 Lake Charles Louisiana 70629 —
Palatin Clinical Site 281 Metairie Louisiana 70002 —
Palatin Clinical Site 257 Annapolis Maryland 21401 —
Palatin Clinical Site 222 Lutherville Maryland 21093 —
Palatin Clinical Site 283 Rockville Maryland 20852 —
Palatin Clinical Site 265 Boston Massachusetts 02131 —
Palatin Clinical Site 217 New Bedford Massachusetts 02740 —
Palatin Clinical Site 239 Kalamazoo Michigan 49009 —
Palatin Clinical Site 245 Saginaw Michigan 48604 —
Palatin Clinical Site 287 Flowood Mississippi 39232 —
Palatin Clinical Site 244 Kansas City Missouri 64114 —
Palatin Clinical Site 280 St Louis Missouri 63043 —
Palatin Clinical Site 220 Lincoln Nebraska 68510 —
Palatin Clinical Site 290 Berlin New Jersey 08009 —
Palatin Clinical Site 233 Lawrenceville New Jersey 08648 —
Palatin Clinical Site 276 Albuquerque New Mexico 87102 —
Palatin Clinical Site 282 Rochester New York 14618 —
Palatin Clinical Site 264 Cary North Carolina 27518 —
Palatin Clinical Site 206 Raleigh North Carolina 27612 —
Palatin Clinical Site 231 Salisbury North Carolina 28144 —
Palatin Clinical Site 209 Winston-Salem North Carolina 27103 —
Palatin Clinical Site 271 Canton Ohio 44718 —
Palatin Clinical Site 215 Cincinnati Ohio 45249 —
Palatin Clinical Site 232 Cleveland Ohio 44122 —
Palatin Clinical Site 246 Columbus Ohio 43212 —
Palatin Clinical Site 221 Mayfield Heights Ohio 44124 —
Palatin Clinical Site 289 Tiffin Ohio 44883 —
Palatin Clinical Site 238 Oklahoma City Oklahoma 73103 —
Palatin Clinical Site 227 Oklahoma City Oklahoma 73112 —
Palatin Clinical Site 267 Allentown Pennsylvania 18104 —
Palatin Clinical Site 234 Philadelphia Pennsylvania 19114 —
Palatin Clinical Site 240 Pittsburgh Pennsylvania 15206 —
Palatin Clinical Site 278 Lincoln Rhode Island 02865 —
Palatin Clinical Site 200 Greer South Carolina 29650 —
Palatin Clinical Site 259 Moncks Corner South Carolina 29461 —
Palatin Clinical Site 275 Chattanooga Tennessee 37403 —
Palatin Clinical Site 216 Jackson Tennessee 38305 —
Palatin Clinical Site 274 Memphis Tennessee 38119 —
Palatin Clinical Site 292 Nashville Tennessee 37201 —
Palatin Clinical Site 235 Arlington Texas 75230 —
Palatin Clinical Site 230 Austin Texas 78731 —
Palatin Clinical Site 223 Dallas Texas 75234 —
Palatin Clinical Site 208 Houston Texas 77054 —
Palatin Clinical Site 269 Draper Utah 84020 —
Palatin Clinical Site 228 West Jordan Utah 84088 —
Palatin Clinical Site 284 Newport News Virginia 23606 —
Palatin Clinical Site 205 Norfolk Virginia 23502 —
Palatin Clinical Site 213 Richmond Virginia 23294 —
Palatin Clinical Site 268 Richmond Virginia 23298 —
Palatin Clinical Site 214 Seattle Washington 98105 —
Palatin Clinical Site 285 Charleston West Virginia 25304 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02338960, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02338960 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →